Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Pathologic Complete Response × X-Rays × 90 days × Clear all

Sponsor

Conditions

Prostatic Neoplasms 14 Lung Neoplasms 8 Neoplasm Metastasis 6 Multiple Myeloma 6 Wilms Tumor 5 Carcinoma, Non-Small-Cell Lung 5 Breast Neoplasms 5 Sarcoma 4 Rhabdoid Tumor 4 Ovarian Neoplasms 4 Osteosarcoma 4 Neuroblastoma 4 Lymphoma, Non-Hodgkin 4 Leukemia, Myeloid, Acute 4 Hepatoblastoma 4 Colorectal Neoplasms 4 Carcinoma, Hepatocellular 4 Triple Negative Breast Neoplasms 3 Neuroectodermal Tumors, Primitive, Peripheral 3 Myelodysplastic Syndromes 3 Melanoma 3 Medulloblastoma 3 Histiocytosis, Langerhans-Cell 3 Glioma 3 Ependymoma 3 Endometrial Neoplasms 3 Central Nervous System Neoplasms 3 Brain Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma, Ewing 2

Interventions

pembrolizumab 2 durvalumab 2 Standard of Care 2 Paclitaxel 2 Oxaliplatin 2 Irinotecan 2 Chemoradiotherapy 2 Carboplatin 2 Capecitabine 2 zanidatamab 1 veliparib 1 tucatinib 1 trilaciclib 1 trebananib 1 trastuzumab duocarmazine 1 tislelizumab 1 tegafur-gimeracil-oteracil 1 talazoparib 1 sarilumab 1 relugolix 1 regorafenib 1 pexidartinib 1 pertuzumab 1 patritumab 1 olaparib 1 niraparib 1 neratinib 1 ganitumab 1 enzalutamide 1 dostarlimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡